2.350EUR-2.08%Mkt Cap: 35.12M EURP/E: 12.83Last update: 2026-05-13
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The compan…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)12.83
P/E (Forward)13.59
PEG7.04
P/B2.35
P/S2.23
EV/EBITDA10.16
EV/Revenue2.02
EPS (TTM)0.18
EPS (Forward)0.17
Cash Flow & Leverage
FCF Yield6.05%
FCF Margin13.51%
Operating CF-748.00K EUR
CapEx (TTM)615.00K EUR
Net Debt/EBITDA-1.04
Net Debt-3.26M EUR
Technical
SMA 502.421 (-2.9%)
SMA 2002.943 (-20.2%)
Beta0.56
S&P 52W Chg24.23%
Avg Vol (30d)9.74K
Avg Vol (10d)8.29K
Technical Indicators
RSI (14)41.3
MACD-0.0078
MACD Signal0.0194
MACD Hist.-0.0272
BB Upper2.774 EUR
BB Middle2.535 EUR
BB Lower2.297 EUR
BB Width18.84%
ATR (14)0.1484 EUR
Vol Ratio (20d)0.84x
52W Range
2.2009% of range3.780
52W High3.780 EUR
52W Low2.200 EUR
Profitability
Gross Margin68.33%
EBITDA Margin19.92%
Profit Margin17.40%
Oper. Margin22.23%
ROE18.33%
ROA13.82%
Revenue Growth21.10%
Earnings Growth32.60%
Balance Sheet
Debt/Equity0.11
Current Ratio2.56
Quick Ratio2.34
Book Value/Sh0.9830 EUR
Cash/Share0.3190 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 15, 2014
Pay Date—
Ownership
Shares Out.12.23M
Float4.50M
Insiders49.85%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)3.500 EUR
Target Range3.500 EUR – 3.500 EUR
# Analysts1
Company
Market Cap35.12M EUR
Enterprise Value31.84M EUR
Revenue (TTM)15.73M EUR
Gross Profit10.75M EUR
Net Income (TTM)2.74M EUR
Revenue/Share1.036 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees46
Last Price2.350 EUR
CountryFI
SectorHealthcare
IndustryMedical Devices
ISIN—